Your session is about to expire
← Back to Search
Digital Health Management Tool for Type 1 Diabetes (KiT Trial)
KiT Trial Summary
This trial is testing whether a digital tool can help young adults with type 1 diabetes feel more confident in managing their disease.
KiT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowKiT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.KiT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a working mobile phone.I am proficient in English or French.I own a mobile device capable of sending and receiving texts.I am getting outpatient care for Type 1 Diabetes at a center involved in this study.I am within 6 months of turning 18 or transferring to adult diabetes care.I have been diagnosed with type 1 diabetes.I am willing to follow the treatment plan if I am selected for the intervention group.I have a valid email address.I am willing to fill out questionnaires throughout the study.
- Group 1: Control
- Group 2: eHealth Tool
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any age restrictions for participation in this medical trial?
"The parameters for eligibility in this trial are narrow, spanning from 17 to 19 years of age. However, there is a larger selection of studies available for people younger than 18 and older than 65 with 216 and 920 trials respectively."
Who has the requisite qualifications to partake in this research trial?
"This trial seeks to recruit 267 adolescents between the ages of 17 and 19 who have type 1 diabetes. To qualify, they must possess a valid mobile phone number, email address, own a smartphone capable of sending/receiving SMS messages, be proficient in English or French language skills and have their medical chart indicate they are suffering from T1D. They will also need to consent to participate within 3-4 months after either planned transfer or turning 18 years old. Furthermore, participants should agree to complete study outcome measures (questionnaires) at all study time-points regardless of which arm they are randomized into: baseline, 6 months and 12"
In what locations is the research experiment being conducted?
"Currently, 6 different medical centres are offering this trial: McGill University Health Centre in Montréal, Oak Valley Health in Markham, The Hospital for Sick Children in Toronto, and 3 other sites."
Is enrollment in this research project still available to the public?
"Clinicaltrials.gov does not indicate that this study is currently recruiting, as it was last updated on October 25th 2022 following its initial posting on December 1st of the same year. However, there are a plethora of alternative clinical trials looking for volunteers at present, totaling 1253 opportunities."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger